Sergio Monsalve

Sergio Monsalve is a partner at Norwest Venture Partners, focusing on early stage investments in marketplaces, mobile applications, on-demand applications, consumer finance, and educational technologies. He holds an MBA from Harvard Business School and a BS in management sciences & engineering (industrial engineering) from Stanford University.

Recent posts

What Startups Need to Attract Talent: A Purposeful Mission
Success for startups is often elusive, but there are underlying characteristics that can give growing companies a leg up on the competition, especially when it comes to the most important factor—recruiting... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
What to Include in Your Life Sciences Company Fundraising Pitch Deck
What the most successful life sciences fundraising pitch decks all have in common
Brex

Sponsored · Webinar
Simple Signaling Reporter Assays – Easily Quantify Activation & Inhibition of Cellular Pathways
Robust, sensitive, & easy-to-use cell-based, reporter gene assays to study signaling pathways
Eurofins DiscoverX

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

AbbVie Wins First FDA Approval of Drug to Treat Uterine Fibroid Bleeds

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

Immunomedics Triple Negative Breast Cancer Drug Wins Early FDA Nod

Lantern Pharma IPO File Illuminates Plan to “Rescue” Failed Cancer Drugs

Pandion Pulls In $80M as Ulcerative Colitis Drug Advances in Clinic

Xcelerating Life Sciences Philadelphia (interactive online event)

Xcelerating Life Sciences San Francisco (interactive online event)

Xcelerating Life Sciences Seattle

Sergio Monsalve

Recent posts

What Startups Need to Attract Talent: A Purposeful Mission

Underwriters and Partners

What to Include in Your Life Sciences Company Fundraising Pitch Deck

Simple Signaling Reporter Assays – Easily Quantify Activation & Inhibition of Cellular Pathways

How to Approach Life Sciences Fundraising

Xconomy on Demand

We offer a number of ways to subscribe for free!